Alto Neuroscience Class Action Lawsuit: Investors May be Entitled to Compensation

Strategic Insights -

Alto Neuroscience's initial public offering conducted on February 2, 2024, and its subsequent stock performance between February 2, 2024, and October 22, 2024, have raised questions about the company's business practices. A class action lawsuit has been filed on behalf of investors who purchased Alto securities during this period, alleging that the company made false and misleading statements about its treatment of major depressive disorder. The lawsuit claims that investors suffered damages when the true details of Alto's business and financial prospects became public.

Key Takeaways:

  • A class action lawsuit has been filed against Alto Neuroscience on behalf of investors who purchased securities during the period from February 2, 2024, to October 22, 2024.
  • The lawsuit alleges that Alto made false and misleading statements about its treatment of major depressive disorder, ALTO-100.
  • Investors who purchased Alto securities during the Class Period may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.
  • A lead plaintiff is needed to direct the litigation, and investors must move the Court by September 19, 2025, to serve in this role.
  • The Rosen Law Firm represents investors throughout the globe and has a track record of success in securities class actions and shareholder derivative litigation.
  • The firm has recovered hundreds of millions of dollars for investors, including the largest-ever securities class action settlement against a Chinese company at the time.
  • Laurence Rosen, founding partner of the Rosen Law Firm, was named a Titan of the Plaintiffs' Bar by Law360 in 2020.

Statistics:

  • The class action lawsuit was filed on September 11, 2025.
  • The Class Period spans from February 2, 2024, to October 22, 2024.
  • The lead plaintiff deadline is set for September 19, 2025.
  • The Rosen Law Firm has recovered over $438 million for investors in 2019 alone.
  • Laurence Rosen has been recognized by Lawdragon and Super Lawyers, and the firm has been ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Sources:

  • Newsfile Corp.
  • The Rosen Law Firm, P.A. (275 Madison Avenue, 40th Floor, New York, NY 10016)
  • Laurence Rosen, Esq.
  • Phillip Kim, Esq.